These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 2182145

  • 1. Platelet transfusions: the problem of refractoriness.
    Murphy MF, Waters AH.
    Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
    [Abstract] [Full Text] [Related]

  • 2. Clinical aspects of platelet transfusions.
    Murphy MF, Waters AH.
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [Abstract] [Full Text] [Related]

  • 3. Clinical aspects of platelet transfusion therapy.
    Murphy MF.
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():34-8. PubMed ID: 7841778
    [Abstract] [Full Text] [Related]

  • 4. Prevention and management of platelet transfusion refractoriness.
    Novotny VM.
    Vox Sang; 1999 Nov; 76(1):1-13. PubMed ID: 9933848
    [Abstract] [Full Text] [Related]

  • 5. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 6. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
    Murphy MF, Brozovic B, Murphy W, Ouwehand W, Waters AH.
    Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
    [Abstract] [Full Text] [Related]

  • 7. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A, Picard C.
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [Abstract] [Full Text] [Related]

  • 8. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions.
    Abraham AS, Chacko MP, Fouzia NA, Srivastava A, Daniel D.
    Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF, Metcalfe P, Thomas H, Eve J, Ord J, Lister TA, Waters AH.
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [Abstract] [Full Text] [Related]

  • 16. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG.
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.